Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I meant Matt's a pussy.
Sorry for the confusion.
A 53-year old pussy.
IGII .17/.18 Buy all you can under .20 It's going to be a big winner
IGII out for a nice gain. Will watch for re-entry much lower
IGII mooooooooo, woooooooopty woooooooopty wooooooooooooo
IGII .75 yr high. Should bust through that soon
IGII keep adding. Buying Buying Buying.
Need .23 to get IMOT money back.
BZET Out from .065 entry.
IGII - I'm all in. Awesome chart. Should see $2
IMOT - LMAO what a pump and dump
EMRI 1.45/1.47 Sweeeeeeeeet news. Great value. Check out what they do and listen to last CC
EMRISE CORPORATION Announces Its Common Shares Have Been Confirmed Eligible for Listing on the Archipelago Exchange(SM)
Wednesday August 3, 8:45 am ET
Stock Anticipated to Trade under New Ticker Symbol ``ERI''
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--Aug. 3, 2005--EMRISE CORPORATION (OTCBB:EMRI - News), a multi-national manufacturer of defense and aerospace electronic components and subsystems and communications equipment, today announced that it has received confirmation of its eligibility to list its shares of common stock on the Archipelago Exchange(SM) (ArcaEx®), a facility of the Pacific Exchange®. Upon listing, which is expected in the near future, EMRISE's shares of common stock are anticipated to trade on ArcaEx under the symbol "ERI."
EMRISE believes that listing on ArcaEx, a regulated national exchange, will broaden EMRISE's potential private and institutional investor base because many private and institutional investors will only purchase stock of a company that is quoted on a national exchange or Nasdaq. A national listing on ArcaEx will provide the opportunity for those investors to participate in ownership of EMRISE common stock.
Jerry Putman, CEO of Archipelago Holdings, the parent company of ArcaEx, stated, "We are especially pleased to have confirmed the listing of shares of common stock of EMRISE as they, like us, are electronic innovators."
Carmine T. Oliva, Chairman, President and CEO of EMRISE stated, "ArcaEx is an innovative, all-electronic national stock exchange and we are pleased that we have been confirmed eligible for listing. Through ArcaEx, our current and future stockholders will gain equal access to all trading information pertaining to EMRISE as ArcaEx's goal is to provide investors with unprecedented openness and transparency to the companies it lists. Most significantly, current and future stockholders will have the opportunity to participate on what we believe will be the best bid and offer the market provides."
EMRI 1.45/1.47 Sweeeeeeeeet news. Great value. Check out what they do and listen to last CC
EMRISE CORPORATION Announces Its Common Shares Have Been Confirmed Eligible for Listing on the Archipelago Exchange(SM)
Wednesday August 3, 8:45 am ET
Stock Anticipated to Trade under New Ticker Symbol ``ERI''
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--Aug. 3, 2005--EMRISE CORPORATION (OTCBB:EMRI - News), a multi-national manufacturer of defense and aerospace electronic components and subsystems and communications equipment, today announced that it has received confirmation of its eligibility to list its shares of common stock on the Archipelago Exchange(SM) (ArcaEx®), a facility of the Pacific Exchange®. Upon listing, which is expected in the near future, EMRISE's shares of common stock are anticipated to trade on ArcaEx under the symbol "ERI."
EMRISE believes that listing on ArcaEx, a regulated national exchange, will broaden EMRISE's potential private and institutional investor base because many private and institutional investors will only purchase stock of a company that is quoted on a national exchange or Nasdaq. A national listing on ArcaEx will provide the opportunity for those investors to participate in ownership of EMRISE common stock.
Jerry Putman, CEO of Archipelago Holdings, the parent company of ArcaEx, stated, "We are especially pleased to have confirmed the listing of shares of common stock of EMRISE as they, like us, are electronic innovators."
Carmine T. Oliva, Chairman, President and CEO of EMRISE stated, "ArcaEx is an innovative, all-electronic national stock exchange and we are pleased that we have been confirmed eligible for listing. Through ArcaEx, our current and future stockholders will gain equal access to all trading information pertaining to EMRISE as ArcaEx's goal is to provide investors with unprecedented openness and transparency to the companies it lists. Most significantly, current and future stockholders will have the opportunity to participate on what we believe will be the best bid and offer the market provides."
EMRI 1.45/1.47 Sweeeeeeeeet news. Great value. Check out what they do and listen to last CC
EMRISE CORPORATION Announces Its Common Shares Have Been Confirmed Eligible for Listing on the Archipelago Exchange(SM)
Wednesday August 3, 8:45 am ET
Stock Anticipated to Trade under New Ticker Symbol ``ERI''
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--Aug. 3, 2005--EMRISE CORPORATION (OTCBB:EMRI - News), a multi-national manufacturer of defense and aerospace electronic components and subsystems and communications equipment, today announced that it has received confirmation of its eligibility to list its shares of common stock on the Archipelago Exchange(SM) (ArcaEx®), a facility of the Pacific Exchange®. Upon listing, which is expected in the near future, EMRISE's shares of common stock are anticipated to trade on ArcaEx under the symbol "ERI."
EMRISE believes that listing on ArcaEx, a regulated national exchange, will broaden EMRISE's potential private and institutional investor base because many private and institutional investors will only purchase stock of a company that is quoted on a national exchange or Nasdaq. A national listing on ArcaEx will provide the opportunity for those investors to participate in ownership of EMRISE common stock.
Jerry Putman, CEO of Archipelago Holdings, the parent company of ArcaEx, stated, "We are especially pleased to have confirmed the listing of shares of common stock of EMRISE as they, like us, are electronic innovators."
Carmine T. Oliva, Chairman, President and CEO of EMRISE stated, "ArcaEx is an innovative, all-electronic national stock exchange and we are pleased that we have been confirmed eligible for listing. Through ArcaEx, our current and future stockholders will gain equal access to all trading information pertaining to EMRISE as ArcaEx's goal is to provide investors with unprecedented openness and transparency to the companies it lists. Most significantly, current and future stockholders will have the opportunity to participate on what we believe will be the best bid and offer the market provides."
EMRI 1.45/1.47 Sweeeeeeeeet news. Great value. Check out what they do and listen to last CC
EMRISE CORPORATION Announces Its Common Shares Have Been Confirmed Eligible for Listing on the Archipelago Exchange(SM)
Wednesday August 3, 8:45 am ET
Stock Anticipated to Trade under New Ticker Symbol ``ERI''
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)--Aug. 3, 2005--EMRISE CORPORATION (OTCBB:EMRI - News), a multi-national manufacturer of defense and aerospace electronic components and subsystems and communications equipment, today announced that it has received confirmation of its eligibility to list its shares of common stock on the Archipelago Exchange(SM) (ArcaEx®), a facility of the Pacific Exchange®. Upon listing, which is expected in the near future, EMRISE's shares of common stock are anticipated to trade on ArcaEx under the symbol "ERI."
EMRISE believes that listing on ArcaEx, a regulated national exchange, will broaden EMRISE's potential private and institutional investor base because many private and institutional investors will only purchase stock of a company that is quoted on a national exchange or Nasdaq. A national listing on ArcaEx will provide the opportunity for those investors to participate in ownership of EMRISE common stock.
Jerry Putman, CEO of Archipelago Holdings, the parent company of ArcaEx, stated, "We are especially pleased to have confirmed the listing of shares of common stock of EMRISE as they, like us, are electronic innovators."
Carmine T. Oliva, Chairman, President and CEO of EMRISE stated, "ArcaEx is an innovative, all-electronic national stock exchange and we are pleased that we have been confirmed eligible for listing. Through ArcaEx, our current and future stockholders will gain equal access to all trading information pertaining to EMRISE as ArcaEx's goal is to provide investors with unprecedented openness and transparency to the companies it lists. Most significantly, current and future stockholders will have the opportunity to participate on what we believe will be the best bid and offer the market provides."
Lois is a reporter at the Daily Planet. Hangs out with a guy in blue tights.
Posted by: cleverrox
In reply to: SAMNOTSAMUEL who wrote msg# 2824
Date:6/28/2005 9:41:05 AM
Post #of 3188
GFCI outstanding shares. Nowhere can I seem to get an accurate count of the shares outstanding and a grip on how many warrants/options are out there. Investor relations phone # is 702.650.3000. I'll be calling to see if I can get an answer.
Bought some more at .46 but very tentative about taking larger position without some better idea of how careful management is about dilution. I would hate for them to buy Global Oil at some terribly dilutive price. I know they barely have any cash on hand.
Sure is lotsa selling
CBAI .34 Well orchestraded Cornell pump and dump
CBAI .36 Talk about a train wreck.
CGCP .585 CNBC segment coming up now about robotic davinci
This is a part of a PR from CGCP a few weeks ago:
Dr. Brunsting has significant experience in this type of surgery, having performed more than 130 robotically-assisted, endoscopic cardiothoracic procedures. He also has conducted many open TMR surgeries using the Cardiogenesis system. With his partner--Dr. Robert S. Binford, M.D.--Dr. Brunsting has also trained other physicians from the U.S., Japan and Australia on the Intuitive Surgical da Vinci robotic system. Dr. Brunsting has been utilizing TMR for the treatment of patients debilitated by angina due to late stage coronary artery disease since 1999.
Congratulations sparky.
I see your plan is coming together nicely. lol
AFPC will be a boooooooooooooooooooooshing.
HESG .87 - Huge news. GNC will be selling SHUGR product. Might make new highs on this. High was about 1.50
RELM - Congrats to all.
Oops. I was the only one to "pick" it. <GGGG>
AFPC 2.25 June 30 projection:
March quarter showed revenue of $6.2 million. AFPC noted they gained much interest in their trade shows they attended in March quarter. So I think revenue can come in at least $6.5 million. At 40% margins they will gross $2.6 million. SG&A should be back to about $1.5 million (March quarter increase was attributed to the trade shows attended so the SG&A should be less June quarter).
Take out the normal $100K R&D and the $22K interest expense and it'll look like this
June 30
Revenue $6.5
COGS 3.9
Gross 2.6
SGA 1.5
R&D .1
Op Inc 1.0
Int Exp .02
Net Inc $980K
Shares 9.4 million
EPS .104 for June quarter
EPS .25 for Y/E June 30
So we're looking at PE of 9 for year. Laughable.
If you notice the volume picked up quite a bit on July 8 and for the next few days. IMO good earnings were "leaked"
PE should be at worst 15 giving us a share price of $3.75 at worst. Also I'd expect AFPC to apply for a listing this quarter.
AFPC 2.25 June 30 projection:
March quarter showed revenue of $6.2 million. AFPC noted they gained much interest in their trade shows they attended in March quarter. So I think revenue can come in at least $6.5 million. At 40% margins they will gross $2.6 million. SG&A should be back to about $1.5 million (March quarter increase was attributed to the trade shows attended so the SG&A should be less June quarter).
Take out the normal $100K R&D and the $22K interest expense and it'll look like this
June 30
Revenue $6.5
COGS 3.9
Gross 2.6
SGA 1.5
R&D .1
Op Inc 1.0
Int Exp .02
Net Inc $980K
Shares 9.4 million
EPS .104 for June quarter
EPS .25 for Y/E June 30
So we're looking at PE of 9 for year. Laughable.
If you notice the volume picked up quite a bit on July 8 and for the next few days. IMO good earnings were "leaked"
PE should be at worst 15 giving us a share price of $3.75 at worst. Also I'd expect AFPC to apply for a listing this quarter.
June 30 projection:
March quarter showed revenue of $6.2 million. AFPC noted they gained much interest in their trade shows they attended in March quarter. So I think revenue can come in at least $6.5 million. At 40% margins they will gross $2.6 million. SG&A should be back to about $1.5 million (March quarter increase was attributed to the trade shows attended so the SG&A should be less June quarter).
Take out the normal $100K R&D and the $22K interest expense and it'll look like this
June 30
Revenue $6.5
COGS 3.9
Gross 2.6
SGA 1.5
R&D .1
Op Inc 1.0
Int Exp .02
Net Inc $980K
Shares 9.4 million
EPS .104 for June quarter
EPS .25 for Y/E June 30
So we're looking at PE of 9 for year. Laughable.
If you notice the volume picked up quite a bit on July 8 and for the next few days. IMO good earnings were "leaked"
PE should be at worst 15 giving us a share price of $3.75 at worst. Also I'd expect AFPC to apply for a listing this quarter.
My "intent" is to show how posters post negatively after they sell and only post positively when they are long. That's all.
I will NOT post here anymore.
And FYI I'm up over 500% this year.
Watch AFPC
See ya.
Bobwins re VPHM. Using your 58 million fully diluted shares and VPHM's guidance of only $75 million in revenue that comes out to about $1.30 per share in sales. So at over $10 per share VPHM looks richly valued. Does it not?
MSGI I was using your reasoning like you did with PDGE. I'm trying to learn from the best. lol
Bobwins what misleading information? I was using MSGI's reasoning as the $2.50 target for VPHM like he did with PDGE. The shares were converted at $2.50 much like the shares will be convertible for PDGE at .90. And today I posted the filing that came out at 3:45.
I guess you have to be in the "inner circle" to post such facts.
Bobwins but since I sold today over $10 after entry at $8 it is my duty to point out every negative I can find.
This way in case it dips I achieve "smart" status and then I buy back shares and start pointing out all the positives.
This investing is fun. Get ready skeedaddy. Soon I'll have my own show.
VPHM filing Sale of Equity = dilution
13-Jul-2005
Sale of Equity
Item 3.02. Unregistered Sales of Equity Securities
On July 12, 2005, ViroPharma Incorporated (the "Company") issued 6,140,000 shares of common stock as a result of the Auto-Conversion of the remaining $15.35 million principal amount of its 6% Convertible Senior Secured Notes due 2009 (the "Senior Convertible Notes") at the conversion rate of one share of common stock for each $2.50 in principal amount of the Senior Convertible Notes. In addition, because the Senior Convertible Notes were Auto-Converted prior to October 18, 2007, the Company made an additional payment on the principal amount Auto-Converted equal to three full years of interest, less interest actually paid or provided for prior to the Auto-Conversion Date (the "Make-Whole Payment"). The Company satisfied the Make-Whole Payment by issuing 381,831 shares of common stock. Additional information regarding the Auto-Conversion and Make-Whole Payment may be found in the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 6, 2005. The foregoing is a summary of the terms of the Auto-Conversion and the Make-Whole Payment and such summary does not purport to be complete and is qualified in its entirety by reference to the full text of the Senior Convertible Notes Indenture, copies of which are attached to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 19, 2004 and incorporated herein by reference.
The common stock was issued in reliance upon the exemption from the registration requirement of the Securities Act of 1933, as amended (the "Securities Act"), afforded by Section 3(a)(9) thereof. Following the Auto-Conversion on July 12, 2005, no additional Senior Convertible Notes remained outstanding.
AFPC buy it. VPHM sell it.
I'm using MSGI's reasoning to come up with this.
AFPC 2.20/2.25 Buy some now. Go ahead. You know you want to. The coming rise is inevitable.
AFPC 2.20 It's ready!
Did I miss the run to $10?
AFPC 2.20 Alot of $$$ to be made here
AFPC <GGGGG>
You lose